Your session is about to expire
← Back to Search
Ga-DOTATATE PETMRI Scan for Abdominal Aortic Aneurysm
N/A
Waitlist Available
Led By Patrick Veit-Haibach
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 6 months after obtaining consent
Awards & highlights
Study Summary
This trial will develop a new imaging tool, PETMRI with radiotracer Ga-DOTATATE, to improve prediction of aneurysm growth and risk in order to better determine who may benefit from surgery.
Who is the study for?
This trial is for individuals over 50 with an asymptomatic abdominal aortic aneurysm (AAA) larger than 3cm, who haven't had previous AAA treatments. They must have prior imaging of their AAA and no contraindications to PET/MRI scans like claustrophobia or implanted devices such as pacemakers.Check my eligibility
What is being tested?
The study is testing a new imaging technique using a PETMRI scan combined with a radiotracer called Ga-DOTATATE. The goal is to improve the prediction of growth and rupture risk in AAAs, potentially leading to better treatment decisions.See study design
What are the potential side effects?
Potential side effects may include reactions to the MRI contrast agent gadolinium or the Ga-DOTATATE drug components, which could range from mild allergic responses to more severe hypersensitivity reactions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 6 months after obtaining consent
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 6 months after obtaining consent
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
68-Ga DOTATATE uptake
Trial Design
1Treatment groups
Experimental Treatment
Group I: Ga-DOTATATE PET/MRI scanExperimental Treatment1 Intervention
Patients with abdominal aortic aneurysm will undergo Ga-DOTATATE PET/MRI scan
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
484,464 Total Patients Enrolled
Patrick Veit-HaibachPrincipal InvestigatorUniversity Health Network, Toronto
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of drinking too much alcohol or using drugs.You have not received treatment for AAA before.You are older than 50 years.You are allergic to the contrast agent used for MRI scans or components of the study drug 68Ga-DOTATATE.You have a pacemaker or implanted cardioverter defibrillator (ICD).You have been diagnosed with an abdominal aortic aneurysm that is larger than 3cm in diameter, but you are not experiencing any symptoms.You need to have had an ultrasound or CT scan of your AAA at least 2 years ago.
Research Study Groups:
This trial has the following groups:- Group 1: Ga-DOTATATE PET/MRI scan
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still vacancies available for participants in this medical trial?
"Per the information provided on clinicaltrials.gov, this medical trial is still taking in participants. It was first made known to the public on February 15th 2021 and has had its details revised as recently as March 19th of this year."
Answered by AI
What is the cap on the number of participants in this trial?
"Affirmative. The information available on clinicaltrials.gov illustrates that this trial is actively recruiting patients, having initially been posted to the site on February 15th 2021 and last updated March 19th 2021. A total of 55 participants are needed from a single location."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger